Product Information
DEFERASIROX 360 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $1.3399 per EA under NDC 62332041230. Its NADAC has been published 223 times since Apr 20, 2022.
FDA first approved this application on Nov 20, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
360 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332041230
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DEFERASIROXApproval Type
Generic (ANDA)
FDA Application
ANDA211824FDA Approved
11/20/2019
TE Code
AB
On Market Since
11/21/2019
Pharmacological Classes
Price Statistics
The NADAC for DEFERASIROX 360 MG TABLET has been published 223 times since Apr 20, 2022, and over the history we have for it it has declined 36.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3399 per EA |
|---|---|
| All-time high | $2.1034 (Apr 12, 2023) |
| All-time low | $1.2249 (Nov 19, 2025) |
| 52-week high | $1.6434 |
| 52-week low | $1.2249 |
| Median price | $1.9511 |
| Average price | $1.7763 |
| Largest weekly change | +29.6% (Mar 18, 2026) |
| Weeks tracked | 223 |
| Tracking since | Apr 20, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEFERASIROX 360 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DEFERASIROX 360 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $1.3399 per EA (NDC 62332041230), effective Aug 19, 2026.
How has the price of DEFERASIROX 360 MG TABLET changed over time?
Over the history we have for it, the NADAC for DEFERASIROX 360 MG TABLET has declined 36.3%. It has been tracked across 223 weekly CMS publications since Apr 20, 2022.
What are the highest and lowest recorded NADAC prices for DEFERASIROX 360 MG TABLET?
Since Apr 20, 2022, the NADAC for DEFERASIROX 360 MG TABLET has ranged from a low of $1.2249 (Nov 19, 2025) to a high of $2.1034 (Apr 12, 2023), with a median of $1.9511 per EA.
Are there cheaper alternatives to DEFERASIROX 360 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEFERASIROX 360 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DEFERASIROX 360 MG TABLET?
DEFERASIROX 360 MG TABLET (NDC 62332041230) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.